Saskia E. Rademakers

906 total citations
12 papers, 691 citations indexed

About

Saskia E. Rademakers is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Saskia E. Rademakers has authored 12 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Saskia E. Rademakers's work include Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (4 papers) and Head and Neck Cancer Studies (3 papers). Saskia E. Rademakers is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (4 papers) and Head and Neck Cancer Studies (3 papers). Saskia E. Rademakers collaborates with scholars based in Netherlands, United States and United Kingdom. Saskia E. Rademakers's co-authors include Johan Bussink, Johannes H.A.M. Kaanders, Albert J. van der Kogel, Paul N. Span, Jasper Lok, Fred C.G.J. Sweep, Ilse J. Hoogsteen, Patricia Doornaert, Chris H.J. Terhaard and Piet van den Ende and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Saskia E. Rademakers

11 papers receiving 685 citations

Peers

Saskia E. Rademakers
Wenny J.M. Peeters Netherlands
Saskia E. Rademakers
Citations per year, relative to Saskia E. Rademakers Saskia E. Rademakers (= 1×) peers Wenny J.M. Peeters

Countries citing papers authored by Saskia E. Rademakers

Since Specialization
Citations

This map shows the geographic impact of Saskia E. Rademakers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia E. Rademakers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia E. Rademakers more than expected).

Fields of papers citing papers by Saskia E. Rademakers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia E. Rademakers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia E. Rademakers. The network helps show where Saskia E. Rademakers may publish in the future.

Co-authorship network of co-authors of Saskia E. Rademakers

This figure shows the co-authorship network connecting the top 25 collaborators of Saskia E. Rademakers. A scholar is included among the top collaborators of Saskia E. Rademakers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saskia E. Rademakers. Saskia E. Rademakers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Vries, Simone de, Inge M. Krul, Michael Schaapveld, et al.. (2023). Risk of male breast cancer after Hodgkin lymphoma. Blood. 142(9). 806–811. 4 indexed citations
3.
Aleman, Berthe M.P., Cécile P.M. Janus, Saskia E. Rademakers, et al.. (2021). Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors.. Journal of Clinical Oncology. 39(15_suppl). 12074–12074. 2 indexed citations
4.
Janssens, Geert O., Saskia E. Rademakers, Chris H.J. Terhaard, et al.. (2014). Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer. Clinical Cancer Research. 20(5). 1345–1354. 29 indexed citations
5.
Rademakers, Saskia E., Ilse J. Hoogsteen, Paul F.J.W. Rijken, et al.. (2013). Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial. Radiotherapy and Oncology. 108(3). 517–522. 21 indexed citations
6.
Stegeman, Hanneke, Saskia E. Rademakers, Paul N. Span, et al.. (2013). Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: Correlation between primary and xenograft tumors. Head & Neck. 36(9). n/a–n/a. 9 indexed citations
7.
Rademakers, Saskia E., Ilse J. Hoogsteen, Paul F.J.W. Rijken, et al.. (2013). Prognostic value of the proliferation marker Ki‐67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial. Head & Neck. 37(2). 171–176. 19 indexed citations
8.
Janssens, Geert O., Saskia E. Rademakers, Chris H.J. Terhaard, et al.. (2012). Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial. Journal of Clinical Oncology. 30(15). 1777–1783. 187 indexed citations
9.
Rademakers, Saskia E., Jasper Lok, Albert J. van der Kogel, Johan Bussink, & Johannes H.A.M. Kaanders. (2011). Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer. 11(1). 167–167. 171 indexed citations
10.
Rademakers, Saskia E., Paul F.J.W. Rijken, Wenny J.M. Peeters, et al.. (2011). Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers. PubMed. 34(2). 119–129. 23 indexed citations
11.
Meijer, Tineke W.H., Olga C.J. Schuurbiers, Johannes H.A.M. Kaanders, et al.. (2011). Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4. Lung Cancer. 76(3). 316–323. 100 indexed citations
12.
Rademakers, Saskia E., Paul N. Span, Johannes H.A.M. Kaanders, et al.. (2008). Molecular aspects of tumour hypoxia. Molecular Oncology. 2(1). 41–53. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026